HALLADAY BENJAMIN (Chief Financial Officer) sold 1.5% of their position (10.77K shares) of ESPERION THERAPEUTICS, INC. on the open market
Open‑market sale worth $34.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/18/2026ACC: 0001628280-26-044264
Officer· Chief Financial Officer
Since Nov 2022
-10.77K
Net shares
Net seller
$34.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.77K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.77K
Price / share
$3.15
Trade value
$33.99K
% of position
1.5%
6/17/2026
713.60K→702.83K
Total
Net shares
−10.77K
Net value
-$33.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2026 | S · Sale | −10.77K | $3.15 | $33.99K | 1.5% | 713.60K | 702.83K |
| Total | −10.77K | -$33.99K | ||||||
Derivative Transactions0
No derivative transactions reported